Role of Intravenous Magnesium Sulphate in Predicting Outcomes of ICU in Acute Organophosphate Poisoning

Journal Title: Indian Journal of Emergency Medicine - Year 2017, Vol 3, Issue 2

Abstract

Organophosphorus chemicals (OPs) are the pesticides most often involved in serious human poisoning in developing countries like India. Treatment of intoxication with OPs conventionally involves atropine for reduction of muscarinic signs and oximes that increase the rate of hydrolysis of the phosphorylated enzyme acetylcholinesterase (AChE). Although oximes (pralidoxime or obidoxime) are traditionally considered specific antidotes and used in the management of such poisoning, their efficacy remains a major issue of debate. Thus, the goal of this clinical study was to elaborate the value of magnesium sulfate (MgSO4) in the management and outcome of acute OP insecticide poisoning. This unicenter, randomized trial study was conducted on patients who were acutely poisoned with OPs and admitted to Kempegowda Institute of Medical Sciences & Hospital. In this study patients where randomly divided into 2 groups (25 patients each). Control group and test group. Control group received conventional management with injection atropine and injection PAM while the test group in addition to above received intravenous Magnesium sulphate. Magnesium sulphate was administered at dose of 4 g/day intravenous infusion over 4 hours within first 24 hours after ingestion. There was a significant decrease in number of days of ventilation (z=2.1, p=0.04) and days of ICU stay(z=4.1, p<0.001) on independent Mann Whitney Tests in patients who received MgSo4 than those who had not received MgSO4. The mortality rate, total atropine required and hospitalization days of patients who received MgSO4 treatment were significantly lower than those who hadnot received MgSO4 (P=<0.05). It is concluded that administration of MgSO4, in a dose of 4 g/day concurrent to conventional therapy, in OP acute human poisoning is beneficial by reducing the hospitalization days and rate of mortality.

Authors and Affiliations

Sri Harsha J

Keywords

Related Articles

Association of Ventilator Associated Pneumonia with Various Risk Factors in Patients at Ahmedabad, Gujarat

Background and Aim: Ventilator associated pneumonia (VAP) is a common complication in critically ill patient affecting 9 to 27% of all critically ill patients. We have done the study of ventilator associated pneumonia (...

Prevalence of Metabolic Syndrome in the Cases of Acute Myocardial Infarction and the Impact of its Components on in-Hospital Prognosis

Introduction: All over the world, with the increasing risk factors like obesity and sedentary lifestyle, it is expected that incidence of Metabolic syndrome (MetS) will be increasing dramatically. It is well established...

Comparison of Lipid Profile between Premenopausal and Postmenopausal Group

Association between menopause and dyslipidemia has been documented by several studies. Several studies have shown that serum LDL & VLDL cholesterol levels, triglycerides are significantly higher and HDL cholesterol level...

Screening for Haemoglobin E in the Ethnic Groups of East Sikkim a Hospital based Study

Background: Haemoglobin E (HbE) is the commonest haemoglobin variant in South East Asia and second most common globally. In India, high prevalence has been reported from the North eastern states and from Bengal. Data reg...

Prognosis of Haemodynamically Unstable Patients Secondary to Trauma Based on Lactate Clearance

TRAUMA is the third overall cause of death and the first cause of death before 40 yr of age [1]. Early recognition of haemorrhage and shock in traumatic patients can prevent death, most deaths (80%) occurring within 48 h...

Download PDF file
  • EP ID EP453293
  • DOI 10.21088/ijem.2395.311X.3217.9
  • Views 101
  • Downloads 0

How To Cite

Sri Harsha J (2017). Role of Intravenous Magnesium Sulphate in Predicting Outcomes of ICU in Acute Organophosphate Poisoning. Indian Journal of Emergency Medicine, 3(2), 231-235. https://europub.co.uk/articles/-A-453293